[1]
|
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2012) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[2]
|
Global Burden of Disease Cancer Collaboration (2019) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 5, 1749-1768.
|
[3]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[4]
|
Herbst, R.S., Heymach, J.V. and Lippman, S.M. (2008) Lung Cancer. The New England Journal of Medicine, 359, 1367-1380. https://doi.org/10.1056/NEJMra0802714
|
[5]
|
Thakur, C. and Chen, F. (2015) Current Understanding of Mdig/MINA in Human Cancers. Genes and Cancer, 6, 288-302.
https://doi.org/10.18632/genesandcancer.73
|
[6]
|
Xu, Z.Y., Blot, W.J., Xiao, H.P., et al. (1989) Smoking, Air Pol-lution, and the High Rates of Lung Cancer in Shenyang, China. JNCI: Journal of the National Cancer Institute, 81, 1800-1806. https://doi.org/10.1093/jnci/81.23.1800
|
[7]
|
Cannon-Albright, L.A., Carr, S.R. and Akerley, W. (2019) Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer. Journal of Tho-racic Oncology, 14, 1184-1191.
https://doi.org/10.1016/j.jtho.2019.04.019
|
[8]
|
Zheng, M. (2016) Classification and Pathology of Lung Cancer. Surgical Oncology Clinics of North America, 25, 447-468. https://doi.org/10.1016/j.soc.2016.02.003
|
[9]
|
Denisenko, T.V., Budkevich, I.N. and Zhivotovsky, B. (2018) Cell Death-Based Treatment of Lung Adenocarcinoma. Cell Death & Disease, 9, Article 117. https://doi.org/10.1038/s41419-017-0063-y
|
[10]
|
钟起祥. 2011-2020年间中国医科大学附属第一医院原发性肺癌手术患者临床特征回顾性分析[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2021. https://doi.org/10.27652/d.cnki.gzyku.2021.001952
|
[11]
|
Greenawalt, E.J., Edmonds, M.D., Jain, N., Adams, C.M., Mitra, R. and Eischen, C.M. (2019) Targeting of SGK1 by MiR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion. Molecular Cancer Research, 17, 289-298.
https://doi.org/10.1158/1541-7786.MCR-18-0364
|
[12]
|
Hirsch, F.R., Scagliotti, G.V., Mulshine, J.L., Kwon, R., Curran Jr, W.J., Wu, Y.L., et al. (2017) Lung Cancer: Current Therapies and New Targeted Treatments. The Lancet, 389, 299-311. https://doi.org/10.1016/S0140-6736(16)30958-8
|
[13]
|
Wood, S.L., Pernemalm, M., Crosbie, P.A. and Whetton, A.D. (2014) The Role of the Tumor-Microenvironment in Lung Cancer-Metastasis and Its Relationship to Po-tential Therapeutic Targets. Cancer Treatment Reviews, 40, 558-566.
https://doi.org/10.1016/j.ctrv.2013.10.001
|
[14]
|
Wang, L., Zhu, B., Zhang, M.M. and Wang, X.D. (2016) Roles of Immune Microenvironment Heterogeneity in Therapy-Associated Biomarkers in Lung Cancer. Seminars in Cell & De-velopmental Biology, 64, 90-97.
https://doi.org/10.1016/j.semcdb.2016.09.008
|
[15]
|
Wintjens, R., Wieruszeski, J.M., Drobecq, H., et al. (2001) 1H NMR Study on the Binding of Pin1 Trp-Trp Domain with Phosphothreonine Peptides. Journal of Biological Chemistry, 276, 25150-25156.
https://doi.org/10.1074/jbc.M010327200
|
[16]
|
Blume-Jensen, P. and Hunter, T. (2001) Oncogenic Kinase Signaling. Nature, 411, 355-365.
https://doi.org/10.1038/35077225
|
[17]
|
Lu, K.P., Liou, Y.C. and Zhou, X.Z. (2002) Pinning down the Pro-line-Directed Phosphorylation Signaling. Trends in Cell Biology, 12, 164-172. https://doi.org/10.1016/S0962-8924(02)02253-5
|
[18]
|
李红雨, 朱涛, 周金华, 等. 短发夹状RNA干扰对子宫颈癌细胞中Pin1基因表达及细胞增值和凋亡的影响[J]. 中华妇产科杂志, 2006, 41(6): 417-421.
|
[19]
|
Rippmann, G.F., Hobbie, S., Daibber, C., et al. (2000) Phosphorylation-Dependent Praline Isomerization Catalyzed by Pin1 Is Es-sential for Tumor Cell Survival and Entry into Mitosis. Cell Growth & Differentiation, 11, 409-416.
|
[20]
|
Motz, G.T., Santoro, S.P., Wang, L.P., et al. (2014) Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors. Nature Medicine, 20, 607-615. https://doi.org/10.1038/nm.3541
|
[21]
|
Rivera, L.B., Meyronet, D., Hervieu, V., et al. (2015) Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy. Cell Reports, 11, 577-591. https://doi.org/10.1016/j.celrep.2015.03.055
|
[22]
|
Falcon, B.L., O’Clair, B., Mc Clure, D., et al. (2013) Development and Characterization of a High-Throughput in vitro Cord Formation Model In-sensitive to VEGF Inhibition. Journal of Hematology&Oncology, 6, Article 31.
https://doi.org/10.1186/1756-8722-6-31
|
[23]
|
Wang, S.H., Cang, S.D. and Liu, D. (2016) Third-Generation Inhibi-tors Targeting EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancer. Journal of Hematology & Oncology, 9, Article No. 34.
https://doi.org/10.1186/s13045-016-0268-z
|
[24]
|
Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991) Can-cer Metastasis and Angiogenesis: An Imbalance of Positive and Negative Regulation. Cell, 64, 327-336. https://doi.org/10.1016/0092-8674(91)90642-C
|
[25]
|
Woodhouse, E.C., Chuaqui, R.F. and Liotta, L.A. (1997) General Mechanisms of Metastasis. Cancer, 80, 1529-1537.
https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F
|
[26]
|
Welsh, S.J., Bellamy, W.T., Briehl, M.M. and Powis, G. (2002) The Redox Protein Thioredoxin-1 (Trx-1) Increases Hypox-ia-Inducible Factor 1 Alpha Protein Expression: Trx-1 Overexpression Results in Increased Vascular Endothelial Growth Factor Production and Enhanced Tumor Angiogenesis. Cancer Research, 62, 5089-5095.
|
[27]
|
Kim, M.R., Choi, H.S., Heo, T.H., Hwang, S.W. and Kang, K.W. (2008) Induction of Vascular Endothelial Growth Factor by Peptidyl-Prolyl Isomerase Pinl in Breast Cancer Cells. Biochemical and Biophysical Research Communications, 369, 547-553. https://doi.org/10.1016/j.bbrc.2008.02.045
|
[28]
|
Lee, C.C., Chen, S.C., Tsai, S.C., Wang, B.W., Liu, Y.C., Lee, H.M. and Shyu, K.G. (2005) Hyperbaric Oxygen Induces VEGF Expression through ERK, JNK and c-Jun/AP-1 Acti-vation in Human Umbilical Vein Endothelial Cells. Journal of Biomedical Science, 13, 143-156. https://doi.org/10.1007/s11373-005-9037-7
|
[29]
|
Textor, B., Sator-Schmitt, M., Richter, K.H., Angel, P. and Schorpp-Kistner, M. (2006) c-Jun and JunB Are Essential for Hypoglycemia-Mediated VEGF Induction. Annals of the New York Academy of Sciences, 1091, 310-318.
https://doi.org/10.1196/annals.1378.076
|
[30]
|
钱颖. 应用RNAi技术抑制Pin1基因表达对宫颈癌生物学行为的影响及其机制研究[D]: [博士学位论文]. 武汉: 华中科技大学, 2008.
|
[31]
|
Bao, L., Kimzey, A., Sauter, G., et al. (2004) Prevalent Overexpression of Proly1 Isomerase Pin1 in Human Cancers. The American Journal of Pathology, 164, 1727-1737. https://doi.org/10.1016/S0002-9440(10)63731-5
|
[32]
|
Ayala, G., Wang, D., Wulf, G., et al. (2003) Pin1 Is a Novel Prognostic Marker in Prostate Cancer. Cancer Research, 63, 6224-6251.
|
[33]
|
Pang, R.W., Lee, T.K., Man, K., et al. (2006) Pin1 Expression Contributes to Hepatic Carcinogenesis. The Journal of Pathology, 210, 19-25. https://doi.org/10.1002/path.2024
|
[34]
|
Ryo, A., Uemura, H., Ishiguro, H., et al. (2005) Stable Suppression of Tu-morigenicity by Pin1-Targeted RNA Interference in Prostate Cancer. Clinical Cancer Research, 11, 7523-7531. https://doi.org/10.1158/1078-0432.CCR-05-0457
|
[35]
|
Volm, M., Koomagi, R. and Mattern, J. (1999) PD-ECGF, bFGF, and VEGF Expression in Non Small Cell Lung Carcinomas and Their Association with Lymph Node Metastasis. Anticancer Research, 19, 651-655.
|
[36]
|
郜娜, 杨庆宇. 基于Notch通路研究南蛇藤提取物对非小细胞肺癌血管生成影响[J]. 热带医学杂志, 2020, 20(3): 341-345.
|
[37]
|
周昊旻. mdig调控非小细胞肺癌脉管生成的分子机制研究[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2021.
https://doi.org/10.27652/d.cnki.gzyku.2021.000437
|
[38]
|
付文娜, 吴琼, 王慧莉. 凝血酶抑制剂亭扎肝素对肺癌血管生成的抑制作用及分子机制研究[J]. 实用临床医药杂志, 2022, 26(7): 67-72, 77.
|
[39]
|
陈璐, 何嘉文, 李姝君. KPT-6566对肺癌细胞增殖、侵袭、凋亡的影响及机制[J]. 山东医药, 2020, 60(31): 19-23.
|
[40]
|
Sasaki, R. (1996) Microvessel Count and Vascular Endothelial Growth Factor in Renal Cell Carcinoma. The Japanese Journal of Urology, 87, 1032-1040. https://doi.org/10.5980/jpnjurol1989.87.1032
|
[41]
|
Huang, C.Y. and Shen, Z.Y. (2002) Vascular Endothelial Growth Factor—Fundamental Research and Experimental Study in Plastic Surgery. Chinese Journal of Re-parative and Reconstructive Surgery, 16, 64-69.
|
[42]
|
Baker, E.A., Bergin, F.G. and Leaper, D.J. (2000) Plasminogen Activator System Vascular Endothelial Growth Factor and Colorectal Cancer Progression. Journal of Molecular Pathol-ogy, 53, 307-312. https://doi.org/10.1136/mp.53.6.307
|
[43]
|
Ravi, R., Mookergee, B., Bhujwalla, Z., et al. (2000) Regulation of Tumor Angiogensis by p53 Induced Degradation of Hypoxia-Inducible Factor 1a. Genes & Development, 14, 34-44. https://doi.org/10.1101/gad.14.1.34
|
[44]
|
Soumitro, P., Kaustubh, D. and Dababtata, M. (2001) Central Role of p53 on Regulation of Vascular Permeability Factor/Vascular Endothelial Factor (VPF/VEGF) Expression in Mammary Carcinoma. Cancer Research, 61, 6952-6956.
|